Silicon Sellout Paper: The Five Risks of An Apple-YMTC Deal

By Jeff Ferry, CPA Chief Economist, and Roslyn Layton, Ph.D., Co-Founder, China Tech Threat This Policy Paper, co-written by Coalition for a Prosperous America (CPA) and China Tech Threat (CTT), highlights the dangers of an impending decision by Apple to begin using Chinese-made memory chips in the iPhone 14. The paper outlines how this creates…

U.S. Challenges in EV Battery Production

By Amanda Mayoral   The U.S. is lagging behind China and the European Union in production of lithium-ion batteries for electric vehicles. Forecasts show the U.S. will fall further behind China by 2025 and remain dependent on imports for more than half of its EV battery needs. This CPA Policy Paper by CPA Economist Amanda…

We Need to be Better at Industrial Policy

We Need to be Better at Industrial Policy By Amanda Mayoral, CPA Economist   Industrial policy is critical to competing in a global economy and maintaining our national security. In the world of U.S. economic policymaking, we need to stop wasting time debating whether to “do” industrial policy and rather debate how to improve it.…

Intel Memory Deal Must Be Re-Examined For China Tech Transfer Threat

Last year, America’s largest chipmaker, Intel, agreed to sell its memory chip business to South Korean memory chipmaker SK Hynix for $9 billion, part of the routine musical chairs of tech companies repositioning their assets. But in the past month, disturbing reports have emerged that China may be imposing forced technology transfer on these companies…

The Global Bicycle Market: A Comprehensive Plan to Re-Shore the U.S. Bike & E-Bike Industry

The United States bike industry is in the midst of an unprecedented boom, triggered by the COVID pandemic. Bike sales rose sharply in the spring of 2020, as gyms, yoga studios and other exercise centers shut down and Americans sought outdoor activities like biking, a relatively safe form of exercise. In 2021, the sales surge…

Generic Drug Shortages and How a Race to the Bottom in Price has Upended 30 years of Hatch-Waxman

CPA’s report, titled “Generic Drug Shortages and How a Race to the Bottom in Price has Upended 30 years of Hatch-Waxman,” details how a loophole in the Hatch-Waxman Act has led to generic drug shortages in the U.S., offshoring of America’s domestic production of generic pharmaceuticals to China and India, and price gouging by foreign…